Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal ...

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

Research confirms the Lumipulse serum p-tau217 assay's effectiveness in diagnosing Alzheimer's, paving the way for accessible ...

Blood biomarkers like tau217, NfL, and GFAP may predict dementia up to 10 years early, but aren't yet reliable for widespread ...

The interaction between the brain and the vascular system could hold the key to lowering disease risk. According to the ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

Manufacturers of Alzheimer’s disease drugs have identified blood tests as a way to accelerate diagnosis and treatment.

Ellen’s experience highlights the growing promise of blood-based testing for Alzheimer’s. By identifying disease-specific biomarkers in the bloodstream, these tests offer a minimally invasive ...

The study supports prior research that found the same thing.

A new study reveals how age, sex, menopause, and genetics influence key blood biomarkers linked to dementia risk.

FRIDAY, April 4, 2025 (HealthDay News) -- An experimental blood test for Alzheimer’s disease not only can aid in its ...